At its second attempt, Astellas has won FDA approval for its first-in-class cancer therapy, Vyloy, which got the green light for certain gastric cancers. The US regulator approved Vyloy (zolbetuximab) ...
What began with a focus on weather forecasting has evolved toward addressing errors in scientific modeling. In the collaborative environment of the Penn State Institute for Computational and Data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback